Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Osteo-Fluidic-Sensitive (OFS) method for frequent tension-type headache

Official title: Evaluation of the Efficacy of the Osteo-Fluidic-sensitive (OFS) Versus Placebo Method in the Management of Frequent Episodic Tension-type Headache. Pilot Study.

Run by Poitiers University Hospital · NCT05229224 · Data updated 2026-11-12

This study will test whether the Osteo-Fluidic-Sensitive (OFS) method can reduce the number of headache days per month in adults with frequent episodic tension-type headache.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment30 (estimated)
SponsorPoitiers University Hospital
Academic / other
Locations1 site (Poitiers)
StatusRecruiting
StartedNovember 29, 2022
Main results expectedMay 29, 2026
Study endsAugust 29, 2026
Registry record updatedJanuary 6, 2026
Trial IDNCT05229224 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–75 years old with highly frequent episodic tension-type headache (2–14 headache days per month) who completed a headache diary and can give informed consent are ideal candidates.

Probably not a fit

People with chronic tension-type headache, migraine-only disorders, cluster headaches, neuralgias, those on excluded medications (e.g., venlafaxine, gabapentin, duloxetine, clomipramine, botulinum toxin), pregnant or breastfeeding women, and those unable to attend the center are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with frequent episodic tension-type headache (2–14 days per month) will be enrolled at CHU Poitiers and receive either the OFS method or a placebo (sham) procedure. Participants will complete a headache diary before and during the 3-month treatment period to measure change in the number of headache days per month. Secondary outcomes include quality of life measures and use of rescue medications. The trial is a pilot, single-center, placebo-controlled interventional comparison to estimate effect size and feasibility.

Why it matters

Potential benefit: If effective, OFS could reduce monthly headache days, improve quality of life, and lower the need for acute headache medications.

How similar studies have gone: This specific OFS method appears novel and has not been widely tested in controlled trials, while related manual and osteopathic approaches have produced mixed results in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 and 75 years' old
* Person having highly frequent episodic tension type headache (between 2 and 14 days of headaches per month) associated or not to headache with characteristic of a migraine per International Classification of Headache Disorders 3rd edition criteria
* Person who completed his headache agenda the month before the study.
* Patient who understands and accepts the effects of the study
* Signed consent
* Person with health insurance coverage

Exclusion Criteria:

* Person having secondary or primary headaches (chronic tension type headache, migraines only, Cluster headaches, Neuralgias ...)
* Person on treatment of venlafaxine, gabapentine, duloxetine, clomipramine et toxine botulique.
* Concomitant participation to another clinical research
* Pregnant or lactating women, women of child-bearing age who do not have effective contraception.
* People with reinforced protection (juvenile), people deprived of liberty per justice or administrative decision, people living in a sanitary and social establishment, adults under legal protection and people in critical medical conditions

Where it's running

  • CHU Poitiers
    Poitiers, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.